Currently out of the existing stock ratings of Daniel Stauder, 25 are a BUY (100%).

Daniel Stauder

Work Performance Price Targets & Ratings Chart

Analyst Daniel Stauder, currently employed at JMP, carries an average stock price target met ratio of 60.42% that have a potential upside of 26.59% achieved within 237 days.

Daniel Stauder’s has documented 49 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on STXS, Stereotaxis at 27-Aug-2026.

Wall Street Analyst Daniel Stauder

Analyst best performing recommendations are on AORT (ARTIVION).
The best stock recommendation documented was for AORT (ARTIVION) at 8/8/2025. The price target of $42 was fulfilled within 3 days with a profit of $1.05 (2.56%) receiving and performance score of 8.55.

Average potential price target upside

AORT Artivion ATRC AtriCure LMAT LeMaitre Vascular STXS Stereotaxis

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 17-Jun-2025

$40

$17.69 (79.29%)

$36

1 months 18 days ago
(18-Aug-2026)

2/6 (33.33%)

$11.1 (38.41%)

28

Buy Since 29-Jan-2020

$44

$21.69 (97.22%)

$44

2 months 16 days ago
(20-Jul-2026)

21/27 (77.78%)

$18.63 (73.43%)

494

Buy Since 23-Oct-2024

$48

$24.39 (103.30%)

$47

4 months 28 days ago
(08-May-2026)

5/6 (83.33%)

$22.59 (88.90%)

131

Hold Since 10-Apr-2026

$42

$19.69 (88.26%)

$38.8

5 months 26 days ago
(10-Apr-2026)

5/6 (83.33%)

$4.37 (11.61%)

195

Buy Since 08-Aug-2022

$55

$31.39 (132.95%)

$32

10 months 29 days ago
(07-Nov-2025)

5/6 (83.33%)

$10.13 (22.58%)

657

Show more analysts

Please expand the browser size to see the chart

Which stock is Daniel Stauder most bullish on?

Potential upside of $48.04 has been obtained for LMAT (LEMAITRE VASCULAR)

Which stock is Daniel Stauder most reserved on?

Potential downside of $1.82 has been obtained for STXS (STEREOTAXIS)

What Year was the first public recommendation made by Daniel Stauder?

On 2023
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?